# DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
> **ANDA211276** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2020-09-15
## Drug
- **FDA Application Number:** ANDA211276
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
- **Generic name:** DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE
- **Active ingredients:** DEXTROSE; SODIUM CHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** BECTON DICKINSON AND COMPANY
- **First approval:** 2020-09-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211276)
---
*MORVS · CC0 1.0*